EDAP TMS SA -ADR (EDAP) Stock News
NASDAQ:EDAP - Nasdaq - US2683111072 - ADR - Currency: USD
EDAP Latest News, Press Relases and Analysis
EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
Company to host conference call and webcast on Thursday, March 27th at 8:30am EDT AUSTIN, Texas, March 6, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the...
EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
EDAP Appoints Glen French to Board of Directors
Cortechs.ai and EDAP Announce World’s First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center
First Focal One® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of California,...
EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures
Company Reports Preliminary Worldwide Record Fourth Quarter Sales of 11 Focal One Systems Record U.S. Fourth Quarter Focal One System Sales Record...
EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures
EDAP Appoints Joshua H. Levine to Board of Directors
PDF Version AUSTIN, Texas, January 10, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies,...
EDAP Appoints Joshua H. Levine to Board of Directors
EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology
AUSTIN, Texas, January 8, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patient...
EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology
Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer
HIFI Study is the largest (N = 3,328) prospective, comparative, multi-center clinical study ever conducted comparing prostate cancer...
EDAP to Participate in the Piper Sandler 36th Annual Healthcare Conference
EDAP Announces Scientific Presentation Highlighting Feasibility of Focal One® to Perform Non-thermal Histotripsy Energy Delivery at the 187th Acoustical Society of America Meeting
Early feasibility work demonstrates Focal One system’s ability to generate histotripsy lesions ex vivo LYON, France, November 22, 2024 -...
EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis
Treatment with robotic HIFU showed reduction in moderate and severe post-operative complications and reduced hospital stay compared to surgery ...
EDAP Reports Third Quarter 2024 Financial Results
EDAP to Participate in the 2024 Jefferies London Healthcare Conference
EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024
Company to host conference call and webcast on Thursday, November 7th at 8:30am EDT LYON, France, October 24, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the...
EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024
EDAP and Avenda Health Launch World’s First AI-Assisted Focal One® Robotic HIFU Procedures
First Unfold AI®-Assisted Focal One procedures successfully performed at the UCLA School of...
EDAP and Avenda Health Launch World’s First AI-Assisted Focal One® Robotic HIFU Procedures
EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
LYON, France, August 29, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes,...
EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
EDAP Reports Second Quarter 2024 Financial Results
Record Q2 2024 total worldwide revenue of EUR 15.8 million (USD 17.0 million) increased 10.6% over Q2 2023Record first half 2024 total...
EDAP Reports Second Quarter 2024 Financial Results
EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024
Company to host conference call and webcast on Wednesday, August 28th at 8:30am EDT LYON, France, August 7, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the...
EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024
EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis
Robotic HIFU therapy continues to maintain an excellent safety profile, confirming positive safety data from prior Phase 1 and 2 studies in...
EDAP Appoints Fran Schulz to Board of Directors
EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations
New appointments bring significant commercial experience with a focus on growing key strategic markets Expands executive leadership in growing...
EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations